BioXcel Therapeutics, Inc. (BTAI)
NASDAQ: BTAI · Real-Time Price · USD
0.8038
+0.0053 (0.66%)
At close: Aug 21, 2026, 4:00 PM EDT
0.8009
-0.0029 (-0.36%)
After-hours: Aug 21, 2026, 7:47 PM EDT
BioXcel Therapeutics Market Cap
BioXcel Therapeutics has a market cap or net worth of $25.16 million as of August 21, 2026. Its market cap has decreased by -65.72% in one year.
Market Cap
25.16M
Enterprise Value
116.77M
1-Year Change
-65.72%
Ranking
Category
Stock Price
$0.80
ChartMarket Cap Chart
Since March 8, 2018, BioXcel Therapeutics's market cap has decreased from $167.60M to $25.16M, a decrease of -84.99%. That is a compound annual growth rate of -20.08%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 25.20M | -28.00% |
| Dec 31, 2025 | 35.00M | 118.75% |
| Dec 31, 2024 | 16.00M | -81.48% |
| Dec 29, 2023 | 86.40M | -85.65% |
| Dec 30, 2022 | 601.90M | 5.82% |
| Dec 31, 2021 | 568.80M | -49.48% |
| Dec 31, 2020 | 1.13B | 327.25% |
| Dec 31, 2019 | 263.50M | 336.26% |
| Dec 31, 2018 | 60.40M | -63.96% |
| Mar 8, 2018 | 167.60M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Talphera | 61.77M |
| SCYNEXIS | 50.74M |
| InterCure | 47.97M |
| Incannex Healthcare | 42.71M |
| China Pharma Holdings | 42.16M |
| Rockwell Medical | 32.65M |
| Optimi Health | 28.36M |
| Aytu BioPharma | 25.44M |